Prelude Capital Management’s Checkpoint Therapeutics CKPT Stock Holding History

Prelude Capital Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-113,081	Closed	-$457K	–	1044
2025 Q1	$457K	Buy	+113,081	New	+$377K	0.03%	536

Prelude Capital Management's CKPT Position: Q2 2025 in Review

Prelude Capital Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 113,081 shares — an estimated $457K sold.

Prelude Capital Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $457K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Prelude Capital Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Prelude Capital Management sold 113,081 Checkpoint Therapeutics shares in Q2 2025, an estimated $457K.
Prelude Capital Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Prelude Capital Management's Checkpoint Therapeutics position peaked at $457K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.